Stryker Corp Stock Forecast for 2023 - 2025 - 2030
Updated on 04/25/2024
Stryker Corp Stock Forecast and Price Target
Based on the current earnings figures, this year's price targets for Stryker Corp were recently set by Twenty four distinguished experts, with an average mark of $366.50. If it reached this goal, it would represent a potential upside of approximately 8.8% from the previous closing price in April, 2024. The high end is $406.00, and the low is $242.00. Even if you're not interested in SYK stock, you may be interested in its competitors.
8.80% Upside
Stryker Corp Fair Value Forecast for 2023 - 2025 - 2030
In the last four years, Stryker Corp's Price has fallen from $184.93 to $0.00 – a 100.00% decrease. Analysts predict that Stryker Corp's Fair Value will increase in the upcoming year, reaching $298.18. This would represent an increase of 100.00%. Over the next seven years, experts predict that Stryker Corp's Fair Value will grow at a rate of 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| EW Stock Forecast | Edwards Lifesciences Corp | Outperform |
11
|
$88.61 | Buy/Sell | $91.18 | 9.47% |
| ZBH Stock Forecast | Zimmer Biomet Holdings | Hold |
15
|
$121.17 | Buy/Sell | $132.52 | 12.24% |
| MSA Stock Forecast | MSA Safety | Outperform |
18
|
$190.72 | Buy/Sell | $192.50 | 0.15% |
| ENOV Stock Forecast | Enovis | Buy |
15
|
$56.17 | Buy/Sell | $70.50 | 33.52% |
| IART Stock Forecast | Integra LifeSciences Holdings | Hold |
16
|
$29.38 | Buy/Sell | $46.60 | 48.06% |
Stryker Corp Revenue Forecast for 2023 - 2025 - 2030
In the last three years, Stryker Corp's Revenue has seen an increase, rising from $14.35B to $20.50B. This represents a growth of 42.83%. Analysts predict that Stryker Corp's Revenue will increase in the upcoming year, reaching $20.93B. This would represent an increase of 2.13%. Over the next seven years, experts predict that Stryker Corp's Revenue will grow at a rate of 23.93%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| ATEC Stock Forecast | Alphatec Holdings | Buy |
7
|
$12.74 | Buy/Sell | $21.85 | 80.53% |
| XENT Stock Forecast | Intersect ENT | - |
6
|
$28.24 | Buy/Sell | $28.25 | -100.00% |
| AVNS Stock Forecast | Avanos Medical | Hold |
11
|
$18.71 | Buy/Sell | $23.50 | 25.60% |
.jpg)
Stryker Corp Dividend per Share Forecast for 2023 - 2025 - 2030
Stryker Corp's Dividend per Share has seen growth In the last two years, going from $2.36 to $2.84 – a gain of 20.34% In the next year, analysts believe that Dividend per Share will reach $3.43 – an increase of 20.77%. For the next seven years, the forecast is forDividend per Share to grow by 38.73%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| CYRX Stock Forecast | Cryoport | Outperform |
8
|
$16.23 | Buy/Sell | $17.61 | 10.91% |
| AORT Stock Forecast | Artivion | Buy |
12
|
$20.92 | Buy/Sell | $24.15 | 19.50% |
| SIBN Stock Forecast | SI-BONE | Buy |
6
|
$15.08 | Buy/Sell | $25.63 | 72.41% |
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| KIDS Stock Forecast | OrthoPediatrics | Outperform |
7
|
$31.20 | Buy/Sell | $41.17 | 23.40% |
| AXGN Stock Forecast | AxoGen | Buy |
6
|
$6.87 | Buy/Sell | $12.50 | 103.78% |
| SMTI Stock Forecast | Sanara MedTech | Buy |
11
|
$32.50 | Buy/Sell | $49.00 | 35.38% |
Stryker Corp EBITDA Forecast for 2023 - 2025 - 2030
Stryker Corp's EBITDA has grown in the last three years, jumping from $3.76B to $4.93B – an increase of 31.40%. In the next year, analysts predict that EBITDA will reach $6.05B – an increase of 22.62%. For the next seven years, the forecast is for EBITDA to grow by 58.26%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| IIN Stock Forecast | IntriCon | - |
10
|
$0.00 | Buy/Sell | $25.00 | 0.00% |
| SPNE Stock Forecast | SeaSpine Holdings | - |
8
|
$9.54 | Buy/Sell | $16.10 | -100.00% |
| LAKE Stock Forecast | Lakeland Industries | Outperform |
16
|
$16.89 | Buy/Sell | $21.50 | 27.29% |
Stryker Corp EBIT Forecast for 2023 - 2025 - 2030
In the last three years, Stryker Corp's EBIT has increased by 32.72%, going from $2.94B to $3.91B. In the next year, analysts are expecting an increase in EBIT, predicting it will reach $5.64B – an increase of 44.40%. The Stryker Corp forecast is for EBIT to reach $7.08B or grow by 81.15%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| CFMS Stock Forecast | Conformis | - |
0
|
$1.55 | Buy/Sell | $2.33 | -100.00% |
| UEEC Stock Forecast | United Health Products | - |
2
|
$0.19 | Buy/Sell | $0.30 | -100.00% |
| RMTI Stock Forecast | Rockwell Medical | Outperform |
7
|
$1.35 | Buy/Sell | $8.00 | 492.59% |
Stryker Corp EPS Price Prediction Forecast for 2023 - 2025 - 2030
In the last four years, Stryker Corp's EPS has fallen from $7.43 to $0.00 – a 100.00% decrease. Analysts predict that Stryker Corp's EPS will increase in the upcoming year, reaching $11.98. This would represent an increase of 100.00%. Over the next seven years, experts predict that Stryker Corp's EPS will grow at a rate of 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| SRGA.Q Stock Forecast | Surgalign Holdings | - |
8
|
$0.01 | Buy/Sell | $3.36 | -100.00% |
| IVC Stock Forecast | Invacare | - |
12
|
$0.02 | Buy/Sell | $1.30 | -100.00% |
| VPRB Stock Forecast | VPR Brands, LP | - |
-13
|
$0.19 | Buy/Sell | $0.00 | -100.00% |
.jpg)